Primary record
(4R,7R)-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide
- 库存
- 1,183 克
- 纯度
- 98.4 %
- CAS
- 511-09-1
化合物标识与属性
- CAS
- 511-09-1
- PubChem CID
- 134551
- SMILES
- CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=CNC7=CC=CC(=C67)C5=C4)C)O
- Canonical SMILES
- CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
名称与同义词
- alpha-Ergocryptine
- Ergocryptine
- Ergokryptine
- alpha-Ergokryptine
- Ergocryptine-alpha
- ?-ergocryptine
- ergokryptin
- |A-Ergocryptine
- a-ergocryptine
- |A-Ergokryptine
- alpha ergocryptine
- I+--Ergocryptine
- Prestwick_1063
- .alpha.-Ergocryptine
- 511-09-1
- 12'-hydroxy-5'
- Bromocriptine Impurity B
- Prestwick0_000727
- Prestwick1_000727
- Prestwick2_000727
- Prestwick3_000727
- RefChem:591060
- Biomol-NT_000068
- D06PXY
- UNII-6WFB60157B
- AC1L34SL
- Bromocriptine EP Impurity B
- YDOTUXAWKBPQJW-NSLWYYNWSA-N
- 6WFB60157B
- SCHEMBL78951
- BSPBio_000654
- CHEMBL1403281
- GTPL271
- CHEBI:10276
- MLS002153977
- DTXSID70893244
- SPBio_002593
- BPBio1_000720
- BPBio1_001360
- NSC 169479
- SCHEMBL29372991
- EINECS 208-121-2
- C32H41N5O5
- DTXCID101323177
- HMS1570A16
- HMS2097A16
- HMS2232C08
- .ALPHA.-ERGOCRYPTINE [MI]
- NSC-169479
- NSC-407319
- MSK40246
- BRN 0078810
- BDBM50390993
- Bromocriptine Mesilate EP Impurity B
- CID134551
- ZINC59796557
- AKOS024282675
- C32-H41-N5-O5
- FE22782
- NSC 407319
- J14.251D
- SMR001233314
- ST057581
- NS00014991
- 4-25-00-00964 (Beilstein Handbook Reference)
- C07545
- 12'-Hydroxy-5'alpha-isobutyl-2'-isopropylergotaman-3',6',18-trione
- Q5385811
- 12'-hydroxy-5'alpha-(2-methylpropyl)-3',6',18-trioxo-2'-(propan-2-yl)ergotaman
- BRD-K74212935-001-03-1
- (6aR,9R)-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
- 12'-Hydroxy-2'-(1-methylethyl)-5'-alpha-(2-methylpropyl)ergotaman-3',6',18-trione
- 12'-hydroxy-2'-(1-methylethyl)-5'alpha-(2-methylpropyl)ergotaman-3',6',18-trione
- Ergotaman-3',6',18-trione, 12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'alpha)-
- (5'|A)-12'-Hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione
- (5'alpha)-12'-Hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione
- 12 -Hydroxy-2 -isopropyl-5 alpha-isobutylergotaman-3 ,6 ,18-trione
- 12'-Hydroxy-2'-(1-methylethyl)-5'-a-(2-methylpropyl)ergotaman-3',6',18-trione
- (4R,7R)-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide
- (6aR,9R)-N-((1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo(7.3.0.02,6)dodecan-4-yl)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo(4,3-fg)quinoline-9-carboxamide
- (6aR,9R)-N-((2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
- 12 -Hydroxy-2 -(1-methylethyl)-5 alpha-(2-methylpropyl)ergotaman-3 ,6 ,18-trione
- 12 inverted exclamation marka-Hydroxy-2 inverted exclamation marka-(1-methylethyl)-5 inverted exclamation marka-|A-(2-methylpropyl)ergotaman-3 inverted exclamation marka,6 inverted exclamation marka,18-trione
- 208-121-2
- Ergotaman-3',6',18-trione, 12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'.alpha.)-
- N-(2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo(7.3.0.02,6)dodecan-4-yl)-6-methyl-6,11-diazatetracyclo(7.6.1.02,7.012,16)hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide